Molecular Markers for the Prediction of Anti-EGFR Monoclonal Antibody Treatment Efficacy in Metastatic Colorectal Cancer

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"Molecular Markers for the Prediction of Anti-EGFR Monoclonal Antibody Treatment Efficacy in Metastatic Colorectal Cancer"
written by Cheng-Bo Han, Jie-Tao Ma, Fan Li, Hua-Wei Zou,
published by Journal of Cancer Therapy, Vol.2 No.5, 2011

has been cited by the following article(s):

[1]	Factores pronósticos y heterogeneidad tumoral en cáncer colorrectal esporádico. Estudio mediante técnicas morfológicas, arrays y secuenciación masiva
	Thesis, 2019

[2]	Numerical analysis of intracellular amino acid profiles of breast cancer cells with K-Ras or PI3K mutation in response to kinase inhibitors
	2018

[3]	Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma
	OncoTargets and therapy, 2017

[4]	DMET™(Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine
	Psychology, 2016

[5]	Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques–the Usefulness in the Qualification of Cancer Patients for Molecularly …
	2015

[6]	Analysis of the involvement of exosomal miRNAs and proteins in the response of CRC cells to Cetuximab
	2014

[7]	Theranostic applications of antibodies in oncology
	Molecular …, 2014

[8]	表皮生长因子受体单克隆抗体疗效预测因素的研究进展
	中华临床医师杂志(电子版), 2013

[9]	期刊订阅
	2013

[10]	EGFR 靶向药物个体化治疗转移性结直肠癌的研究进展
	中国新药杂志, 2012

[1]	Numerical analysis of intracellular amino acid profiles of breast cancer cells with K-Ras or PI3K mutation in response to kinase inhibitors BMC Cancer, 2018 DOI:10.1186/s12885-018-4972-7

[2]	DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine Oncotarget, 2016 DOI:10.18632/oncotarget.9927

[3]	Theranostic applications of antibodies in oncology Molecular Oncology, 2014 DOI:10.1016/j.molonc.2014.03.010

[4]	Theranostic applications of antibodies in oncology Molecular Oncology, 2014 DOI:10.1016/j.molonc.2014.03.010

Follow SCIRP